CN1850812A - 咪唑衍生物,其制备方法和用于抗结核杆菌的药物 - Google Patents
咪唑衍生物,其制备方法和用于抗结核杆菌的药物 Download PDFInfo
- Publication number
- CN1850812A CN1850812A CN 200510025327 CN200510025327A CN1850812A CN 1850812 A CN1850812 A CN 1850812A CN 200510025327 CN200510025327 CN 200510025327 CN 200510025327 A CN200510025327 A CN 200510025327A CN 1850812 A CN1850812 A CN 1850812A
- Authority
- CN
- China
- Prior art keywords
- acid
- compound
- formula
- group
- atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
药物 | MIC(μg/ml) | ED 50(μg/ml) |
对氨基水杨酸 | 8 | 1.68±0.37 |
异烟肼 | 6 | 4.23±0.96 |
利福平 | >64 | >64 |
式(III)化合物 | 1 | 0.19 |
成分 | 每片含量 |
实施例1制备的式(III)化合物 | 50mg |
乳糖 | 100mg |
玉米淀粉 | 40mg |
硬脂酸镁 | 10mg |
总量 | 200mg |
成分 | 每片含量 |
实施例1制备的式(III)化合物 | 50mg |
利福平 | 30mg |
乳糖 | 70mg |
玉米淀粉 | 40mg |
硬脂酸镁 | 10mg |
总量 | 200mg |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2005100253275A CN1850812B (zh) | 2005-04-22 | 2005-04-22 | 咪唑衍生物,其制备方法和用于抗结核杆菌的药物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2005100253275A CN1850812B (zh) | 2005-04-22 | 2005-04-22 | 咪唑衍生物,其制备方法和用于抗结核杆菌的药物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1850812A true CN1850812A (zh) | 2006-10-25 |
CN1850812B CN1850812B (zh) | 2010-09-08 |
Family
ID=37132314
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2005100253275A Active CN1850812B (zh) | 2005-04-22 | 2005-04-22 | 咪唑衍生物,其制备方法和用于抗结核杆菌的药物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1850812B (zh) |
-
2005
- 2005-04-22 CN CN2005100253275A patent/CN1850812B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN1850812B (zh) | 2010-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6200958B1 (en) | Agent for treating high-risk impaired glucose tolerance | |
CN1108153C (zh) | 含奥丹亚龙的口服组合物 | |
JP2013545730A5 (zh) | ||
RU2005102110A (ru) | Способ и лекарственное средство для лечения тяжелой сердечной недостаточности | |
JPH0372463A (ja) | 腎機能改善剤 | |
CN115400140A (zh) | 呋喃核糖基吡啶衍生物用于预防或治疗癫痫或惊厥的用途 | |
JP2007524661A (ja) | 長期鎮静のためのプロポフォールの水溶性プロドラッグの投与の方法 | |
CN1077790C (zh) | 青光眼治疗剂及眼压降低剂 | |
JP5584518B2 (ja) | ジアミノトリフルオロメチルピリジン誘導体を含有する抗ショック剤 | |
CN1850812B (zh) | 咪唑衍生物,其制备方法和用于抗结核杆菌的药物 | |
RU2440113C2 (ru) | Фармацевтическая композиция для инъекционного особенно целенаправленного местного применения | |
JP7110196B2 (ja) | カルバメート化合物を含む非経口用液剤 | |
CN1447688A (zh) | 使用苯甲酰苯乙酸治疗与血管生成相关疾病的方法 | |
KR101082802B1 (ko) | 8-하이드록시클로미프라민 또는 그의 염을 포함하는 조루의 예방 또는 치료용 약학 조성물 | |
JP2010509389A (ja) | 化学療法剤により誘起された末梢神経毒性の処置に有効なピロロ[1,2−a]イミダゾールジオン | |
JP5462797B2 (ja) | 注射可能なメクリジン製剤および方法 | |
JP2005503323A5 (zh) | ||
JP2014098017A (ja) | 過敏性腸症候群(ibs)を処置するための4−[2−(4−メチルフェニルスルファニル)フェニル]ピペリジン | |
RU2007111704A (ru) | 4[(2,4-дихлоро-5-метоксифенил)амино]-6-алкокси-7-этинил-3-хинолинкарбонитрилы для лечения ишемического поражения | |
CN105801663A (zh) | 一种熊果酸小檗碱偶合物的制备方法及医药用途 | |
CA2516629A1 (en) | Compositions and methods for preventing and treating endotoxin-related diseases and conditions | |
KR101169633B1 (ko) | 신기능 장해 개선제 | |
JP2021167279A (ja) | ミトコンドリア病の予防または治療のための医薬組成物 | |
WO2024010030A1 (ja) | 血中マイオスタチン低下剤 | |
WO2013032184A2 (ko) | 피라지노-트리아진 유도체를 포함하는 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Chen Xuwen Document name: Written notice of preliminary examination of application for patent for invention |
|
C06 | Publication | ||
PB01 | Publication | ||
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Chen Xuwen Document name: Notice of publication of application for patent for invention |
|
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Xu Xun Document name: Notice of conformity |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI LIANHE SAIER BIOLOGY ENGINEERING CO., LTD Free format text: FORMER OWNER: JIANNENGLONG MEDICINE TECHNOLOGY ( SHANGHAI ) CO., LTD. Effective date: 20091002 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20091002 Address after: 1150 Jinqiao Road, Pudong New Area, Shanghai, China Code: 201206 Applicant after: SHANGHAI UNITED CELL BIOTECHNOLOGY Co.,Ltd. Address before: Room A214, 899 Harley Road, Zhangjiang hi tech park, Shanghai, China: 201203 Applicant before: GENERON (SHANGHAI) Corp.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Imidazole derivatives, preparation method thereof, and drugs for anti tuberculosis bacteria Effective date of registration: 20230829 Granted publication date: 20100908 Pledgee: China Minsheng Banking Corp Shanghai branch Pledgor: SHANGHAI UNITED CELL BIOTECHNOLOGY Co.,Ltd. Registration number: Y2023310000493 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |